Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: An abnormal permeability barrier homeostasis with defective processing to generate ceramide

Archives of Dermatological Research

Volumn 306, Issue 5, 2014, Pages 427-440

  Sugiura, Ayumi ^a   Nomura, Tsuyoshi ^a   Mizuno, Atsuko ^b   Imokawa, Genji ^a,c  

^a TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^b Higashi Matsubara Dermatological Clinic   (Japan)

^c CHUBU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Ceramide; Skin barrier function; Sphingolipid metabolism; Stratum corneum

Indexed keywords

CERAMIDE; GLUCOSYLCERAMIDASE; SPHINGOLIPID;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DRY SKIN; ENZYME ACTIVITY; EPIDERMIS; FEMALE; HOMEOSTASIS; HUMAN; MALE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STRATUM CORNEUM; UPREGULATION; WATER CONTENT; WATER LOSS; YOUNG ADULT; BIOSYNTHESIS; ECZEMA; METABOLISM; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; THERMOREGULATION;

ADULT; CERAMIDES; DERMATITIS, ATOPIC; ECZEMA; EPIDERMIS; FEMALE; GLUCOSYLCERAMIDASE; HUMANS; MALE; PERMEABILITY; SPHINGOLIPIDS; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 84903793696     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1430-x     Document Type: Article

References (45)

1. Angelova-Fischer I, Mannheimer AC, Hinder A, Ruether A, Franke A, Neubert RH, Fischer TW, Zillikens D (2011) Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling. Exp Dermatol 20:351-356
2. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G (2002) Decreased levels of sphingosine, a natural anti-microbial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 119:433-439
3. Di Nardo A, Wertz P, Giannetti A, Seidenari S (1998) Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78:27-30 (Pubitemid 28103674)
4. Fartasch M, Bassukas ID, Diepgen TL (1992) Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 127:221-227
5. Feingold KR, Man MQ, Proksch E, Menon GK, Brown BE, Elias PM (1991) The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia. J Invest Dermatol 96:201-209
6. Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92 (Suppl.):44-47
7. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G (2000) High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115:406-413
8. Hata M, Tokura Y, Takigawa M, Sato M, Shioya Y, Fujikura Y, Imokawa G (2002) Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis. Lab Invest 82:1451-1461 (Pubitemid 35332905)
9. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G (2000) The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 350:747-756
10. Holleran WM, Feingold KR, Man M-Q, Gao WN, Lee JM, Elias PM (1991) Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158
11. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR (1991) Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 88:1338-1345
12. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM (1993) Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 91:1656-1664 (Pubitemid 23127370)
13. Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E (1994) Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 93:1756-1764
14. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM (1994) Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res 35:905-912 (Pubitemid 24157241)
15. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96:523-526
16. Imokawa G, Kuno H, Kawai M (1991) Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol 96:845-851
17. Imokawa G, Yada Y, Higuchi K, Okuda M, Ohashi Y, Kawamata A (1994) Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid deficient rats and has an inhibitory effect on epidermal hyperplasia. J Clin Invest 94:89-96 (Pubitemid 24218080)
18. Imokawa G (1999) Skin moisturizers: development and clinical use ceramides. In: Loden M (ed) Dry skin and moisturizers. CRC Press, Boca Raton, pp 269-299
19. Imokawa G (2002) Ceramides as natural moisturizing factors and their efficacy in dry skin. In: Leyden JJ, Rawlings AV (eds) Skin moisturization. Marcel Dekker Inc., New York, pp 267-302
20. Imokawa G (2004) Surfactant-induced depletion of ceramides and other intercellular lipids: implication for the mechanism leading to dehydration of the stratum corneum. Exog Dermatol 3:81-98
21. Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Oguchi K, Imokawa G (2003) The abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase and the accumulation of its enzymatic reaction product, glucosylsphingosine in the skin of patients with atopic dermatitis. Lab Invest 88:397-408 (Pubitemid 36351001)
22. Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y, Kitahara T, Takema Y, Koyano S, Yamazaki S, Hatamochi A (2010) Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 130:2511-2514
23. Jensen JM, Fölster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schütze S, Proksch E (2004) Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 122:1423-1431 (Pubitemid 38757224)
24. Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G (1994) Analysis of beta-glucocerebrosidase and ceramidase activity in atopic and aged dry skin. Acta Derm Venereol 74:337-340 (Pubitemid 24305843)
25. Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Høgh JK, Hellgren LI, Jemec GB, Agner T, Weidinger S (2010) Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 65:911-918
26. Kikuchi K, Kobayashi H, O'goshi K, Tagami H (2006) Impairment of skin barrier function is not inherent in atopic dermatitis patients: a prospective study conducted in newborns. Pediatr Dermatol 23:109-113
27. Kusuda S, Cui CY, Takahashi M, Tezuka T (1998) Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol 111:733-738 (Pubitemid 28509310)
28. Mao-Qiang M, Feingold KR, Elias PM (1993) Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. J Invest Dermatol 101:185-190 (Pubitemid 23218696)
29. Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T, Takema Y, Kita K (2008) Characterization of overall ceramide species in human stratum corneum. J Lipid Res 49:1466-1476
30. Masukawa Y, Narita H, Sato H, Naoe A, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T (2009) Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res 50:1708-1719
31. Matsuki H, Kiyokane K, Matsuki T, Sato S, Imokawa G (2004) Re-characterization of the non-lesional dry skin in atopic dermatitits through disrupted barrier function. Exog Dermatol 3:282-292 (Pubitemid 43927354)
32. Matsuki H, Kiyokane K, Matsuki T, Sato S, Imokawa G (2004) Re-evaluation of the importance of barrier dysfunction in the non-lesional dry skin of atopic dermatitis through the use of two barrier creams. Exog Dermatol 3:293-302 (Pubitemid 43927355)
33. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R (1993) Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1182:147-151 (Pubitemid 23267037)
34. Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K, Tsuchiya T, Kawaminami S, Imokawa G (1996) Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 106:1242-1249 (Pubitemid 26195849)
35. Nogami-Itoh M, Teranishi Y, Kuwahara H, Kusumoto M, Nakamura K, Matsumoto M, Sakai J, Kimura T, Kawashima M (2010) Purification and identification of sphingomyelin deacylase from rat skin. J Invest Dermatol 13 (Suppl.2):s24
36. Okamoto R, Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Imokawa G (2003) Sphingosylphosphorylcholine levels are significantly increased in the stratum corneum of patients with atopic dermatitis: physiological and functional relevance of sphingomyelin deacylase to the ceramide deficiency. J Lipid Res 44:93-102
37. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-446
38. Sandilands A, O'Regan GM, Liao H, Zhao Y, Terron-Kwiatkowski A, Watson RM, Cassidy AJ, Goudie DR, Smith FJ, McLean WH, Irvine AD (2006) Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 126:1770-1775 (Pubitemid 44086511)
39. Sandilands A, Smith FJ, Irvine AD, McLean WH (2007) Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 127:1282-1284 (Pubitemid 46763004)
40. Schmuth M, Man MQ, Weber F, Gao W, Feingold KR, Fritsch P, Elias PM, Holleran WM (2000) Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 115:459-466
41. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H, Evans AT, Goudie DR, Lewis-Jones S, Arseculeratne G, Munro CS, Sergeant A, O'Regan G, Bale SJ, Compton JG, DiGiovanna JJ, Presland RB, Fleckman P, McLean WH (2006) Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38:337-342
42. Takagi Y, Nakagawa H, Higuchi K, Imokawa G (2005) Characterization of surfactant-induced skin damage through barrier recovery induced by pseudoacylceramide. Dermatology 211:128-134 (Pubitemid 41160248)
43. Takagi Y, Kriehuber E, Imokawa G, Elias PM, Holleran WM (1999) Beta-glucocerebrosidase activity in mammalian stratum corneum. J Lipid Res 40:861-869 (Pubitemid 29220527)
44. Tanaka M, Zhen YX, Tagami H (1997) Normal recovery of the stratum corneum barrier function following damage induced by tape stripping in patients with atopic dermatitis. Br J Dermatol 136:966-967 (Pubitemid 27283537)
45. Yoshida N, Sawada E, Imokawa G (2012) A reconstructed human epidermal keratinization culture model to characterize ceramide metabolism in the stratum corneum. Arch Dermatol Res 304:563-577